Hudson Bay Capital Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Hudson Bay Capital Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,929	Closed	-$2.05K	–	847
2023 Q2	$2.05K	Hold	51,929	–	–	﹤0.01%	821
2023 Q1	$7.16K	Hold	51,929	–	–	﹤0.01%	794
2022 Q4	$2.7K	Hold	51,929	–	–	﹤0.01%	930
2022 Q3	$4K	Sell	51,929 -23,671	-31%	-$4K	﹤0.01%	1169
2022 Q2	$23K	Sell	75,600 -2,300	-3%	-$511	﹤0.01%	1162
2022 Q1	$18K	Hold	77,900	–	–	﹤0.01%	1116
2021 Q4	$39K	Sell	77,900 -4,600	-6%	-$2.27K	﹤0.01%	1021
2021 Q3	$34K	Buy	+82,500	New	+$33.8K	﹤0.01%	942

Other funds holding ESLAW

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Hudson Bay Capital Management's ESLAW Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of Estrella Immunopharma Warrant (ESLAW) in Q3 2023, closing a stake of 51,929 shares — an estimated $2.05K sold.

Hudson Bay Capital Management first reported a position in ESLAW in Q3 2021 and held it in 8 quarters. The position peaked at $39K in Q4 2021. 11 funds tracked by Wall St. Rank hold ESLAW as of Q3 2023.

Hudson Bay Capital Management reported no remaining Estrella Immunopharma Warrant position as of Q3 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 51,929 Estrella Immunopharma Warrant shares in Q3 2023, an estimated $2.05K.
Hudson Bay Capital Management first reported a position in Estrella Immunopharma Warrant in Q3 2021 and held it in 8 quarters.
Hudson Bay Capital Management's Estrella Immunopharma Warrant position peaked at $39K in Q4 2021.
11 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.